TABLE 5.
Changes in anthropometric measurements, body composition, and metabolic variables in response to a hypocaloric low-carbohydrate (n = 12) and low-fat diet (n = 12)
Variable | Low-carbohydrate diet |
Low-fat diet |
Between-group P† | ||||
---|---|---|---|---|---|---|---|
Before diet | After diet | P* | Before diet | After diet | P* | ||
Weight (kg) | 97.7 ± 14.4 | 90.3 ± 12.9 | <0.01 | 91.5 ± 11.1 | 85.0 ± 11.2 | <0.01 | 0.40 |
BMI (kg/m2) | 34.5 ± 4.2 | 31.9 ± 3.9 | <0.01 | 32.8 ± 3.0 | 30.5 ± 3.0 | <0.01 | 0.51 |
Waist circumference (cm) | 107.0 ± 11.1 | 102.4 ± 10.4 | <0.01 | 105.1 ± 9.0 | 100.0 ± 8.5 | <0.01 | 0.63 |
DEXA fat body mass (kg) | 38.8 ± 8.5 | 34.9 ± 9.0 | <0.01 | 37.3 ± 6.5 | 33.5 ± 6.6 | <0.01 | 0.89 |
DEXA lean body mass (kg) | 54.4 ± 11.2 | 51.6 ± 9.8 | <0.01 | 50.3 ± 9.9 | 48.6 ± 9.8 | <0.01 | 0.19 |
DEXA % body fat | 40.5 ± 6.6 | 38.9 ± 7.2 | 0.03 | 41.5 ± 6.4 | 39.7 ± 7.1 | <0.01 | 0.77 |
Fasting plasma glucose (mmol/l) | 5.5 ± 0.8 | 5.4 ± 0.7 | 0.78 | 5.6 ± 0.5 | 5.4 ± 0.4 | 0.32 | 0.69 |
Fasting serum insulin (mU/l) | 12.5 ± 6.2 | 7.4 ± 3.8 | 0.01 | 11.4 ± 6.1 | 9.0 ± 4.4 | 0.02 | 0.17 |
A1C (%) | 5.3 ± 0.3 | 5.2 ± 0.003 | <0.01 | 5.4 ± 0.3 | 5.3 ± 0.4 | 0.41 | 0.36 |
GIR (μmol · kg−1 · min−1) | 23.5 ± 7.4 | 28.3 ± 6.9 | 0.02 | 28.3 ± 9.5 | 30.2 ± 8.5 | 0.39 | 0.28 |
Total cholesterol (mmol/l) | 4.65 ± 1.06 | 4.05 ± 0.82 | 0.06 | 5.00 ± 0.99 | 4.12 ± 1.00 | <0.01 | 0.43 |
LDL cholesterol (mmol/l) | 2.46 ± 1.08 | 2.1 ± 0.78 | 0.05 | 2.85 ± 0.88 | 2.41 ± 0.76 | 0.01 | 0.64 |
HDL cholesterol (mmol/l) | 1.47 ± 0.40 | 1.35 ± 0.32 | 0.11 | 1.40 ± 0.39 | 1.15 ± 0.30 | <0.01 | 0.12 |
Triglycerides (mmol/l) | 1.59 ± 0.55 | 0.91 ± 0.33 | <0.01 | 1.55 ± 0.90 | 1.43 ± 0.57 | 0.44 | 0.01 |
Leptin (ng/ml) | 35.6 ± 20.5 | 18.9 ± 18.3 | <0.01 | 36.1 ± 18.7 | 22.6 ± 15.5 | <0.01 | 0.30 |
Retinol binding protein 4 (μg/ml) | 30.6 ± 4.6 | 26.5 ± 10.7 | 0.18 | 30.2 ± 14.6 | 24.0 ± 5.2 | 0.11 | 0.63 |
Data are means ± SD.
*Within-group comparisons analyzed by paired-samples t test.
†Between-group comparisons analyzed by ANOVA. GIR, glucose infusion rate during euglycemic clamp.